These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1327802)

  • 21. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
    Zhang Q; Brooks L; Busson P; Wang F; Charron D; Kieff E; Rickinson AB; Tursz T
    Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferred size of peptides that bind to H-2 Kb is sequence dependent.
    Deres K; Schumacher TN; Wiesmüller KH; Stevanović S; Greiner G; Jung G; Ploegh HL
    Eur J Immunol; 1992 Jun; 22(6):1603-8. PubMed ID: 1376267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
    J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.
    Zhang QJ; Gavioli R; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2217-21. PubMed ID: 8384718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.
    Casey JL; Coley AM; Street G; Parisi K; Devine PL; Foley M
    J Clin Microbiol; 2006 Mar; 44(3):764-71. PubMed ID: 16517852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide.
    Barouch D; Davenport M; McMichael A; Reay P
    Int Immunol; 1995 Oct; 7(10):1599-605. PubMed ID: 8562505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fate of the three subunits of major histocompatibility complex class I molecules.
    Neefjes JJ; Smit L; Gehrmann M; Ploegh HL
    Eur J Immunol; 1992 Jun; 22(6):1609-14. PubMed ID: 1318200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool.
    Fiebiger BM; Moosmann A; Behrends U; Mautner J
    Eur J Immunol; 2012 Dec; 42(12):3167-73. PubMed ID: 22944914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation.
    Hahn S; Setz C; Wild J; Schubert U
    J Immunol; 2011 May; 186(10):5706-18. PubMed ID: 21482733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides.
    Choppin J; Martinon F; Gomard E; Bahraoui E; Connan F; Bouillot M; Lévy JP
    J Exp Med; 1990 Sep; 172(3):889-99. PubMed ID: 2388036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group.
    Parkkonen P; Hyöty H; Ilonen J; Reijonen H; Ylä-Herttuala S; Leinikki P
    Clin Exp Immunol; 1994 Feb; 95(2):287-93. PubMed ID: 7508347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreasing the configurational entropy and the hydrophobicity of EBV-derived peptide 11389 increased its antigenicity, immunogenicity and its ability of inducing IL-6.
    Urquiza M; Guevara T; Rodriguez C; Melo-Cardenas J; Vanegas M; Patarroyo ME
    Amino Acids; 2012 Jun; 42(6):2165-75. PubMed ID: 21674161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.
    Spriggs MK; Armitage RJ; Comeau MR; Strockbine L; Farrah T; Macduff B; Ulrich D; Alderson MR; Müllberg J; Cohen JI
    J Virol; 1996 Aug; 70(8):5557-63. PubMed ID: 8764069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio.
    Dillner J; Rabin H; Letvin N; Henle W; Henle G; Klein G
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1587-96. PubMed ID: 2438377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity.
    Elvin J; Potter C; Elliott T; Cerundolo V; Townsend A
    J Immunol Methods; 1993 Feb; 158(2):161-71. PubMed ID: 7679131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of MHC class I downregulation in HIV infected cells.
    Kerkau T; Gernert S; Kneitz C; Schimpl A
    Immunobiology; 1992 Apr; 184(4-5):402-9. PubMed ID: 1350567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of widespread binding of HLA class I molecules to peptides.
    Frelinger JA; Gotch FM; Zweerink H; Wain E; McMichael AJ
    J Exp Med; 1990 Sep; 172(3):827-34. PubMed ID: 2201749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class I presentation of an exogenous polypeptide antigen encoded by the murine AIDS defective virus.
    Yee ST; Okada Y; Ogasawara K; Omura S; Takatsuki A; Kakiuchi T; Muno D; Kominami E; Mizuochi T
    Microbiol Immunol; 1997; 41(7):563-70. PubMed ID: 9272702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of H-2Kb-, Db- and Dd-binding peptides derived from amino acid sequences of polyoma virus T antigens.
    Reinholdsson-Ljunggren G; Franksson L; Dalianis T; Ljunggren HG
    Int J Cancer; 1993 Jul; 54(6):992-5. PubMed ID: 8335406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.
    Moss DJ; Misko IS; Sculley TB; Apolloni A; Khanna R; Burrows SR
    Springer Semin Immunopathol; 1991; 13(2):147-56. PubMed ID: 1724100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.